Neuropathic pain is an ongoing and distressing issue for many pediatric cancer patients. This quick hit session will provide an overview of pharmacological interventions to manage neuropathic pain in this patient population, including the use of gabapentin, pregabalin, amitriptyline, and duloxetine.
Deepa Kattail, MD, MHS, FAAP,
Pediatric Anesthesiology and Pediatric Pain Physician,
McMaster Children’s Hospital,
Hamilton Health Sciences
Dr. Deepa Kattail is board certified in anesthesiology and pediatric anesthesiology by the American Board of Anesthesiology and is a subspecialty fellow of the American Academy of Pediatrics. She received her medical degree from Kasturba Medical College, India. Her post-graduate clinical training included a surgical internship in Detroit, Michigan, followed by an anesthesia residency at Rush Medical Center in Chicago. Dr. Kattail then completed a fellowship in pediatric anesthesiology at The Johns Hopkins University School of Medicine in Baltimore. From 2013-2017, she was a staff physician at Johns Hopkins in the Division of Pediatric Anesthesia and Pediatric Pain. She was awarded a master’s degree in health science in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Public Health in 2017. She is also actively involved in the Society of Pediatric Pain Medicine and is currently chair of the communications committee. Currently, she is a staff physician at McMaster Children’s Hospital and divides her time between pediatric anesthesiology, the pediatric chronic pain program and academic and research activities at McMaster University. Her research interests are focused on clinical aspects of pediatric pain.